Pediatrix Medical Group (NYSE:MD) reported fourth-quarter results that matched its recently raised internal projections, as the company’s multi-year restructuring begins to yield a more predictable, hospital-centric financial profile.
EPAM Systems (NYSE:EPAM) delivered a robust fourth-quarter performance, signaling that its aggressive pivot into "AI-native" services is paying off as the company closes out a pivotal fiscal year.
NICE (NASDAQ:NICE) reported fourth-quarter financial results that significantly outpaced the prior year, driven by a surge in enterprise adoption of its AI-powered cloud platforms and a disciplined focus on operating efficiency.
Merck (NYSE:MRK) released new data today demonstrating that its recently approved monoclonal antibody, Enflonsia (clesrovimab), remains safe and effective for high-risk children entering their second respiratory syncytial virus (RSV) season.
Boeing (NYSE:BA) finalized a massive agreement with Vietnam Airlines for 50 737-8 MAX airplanes, a deal valued at approximately $8.1 billion at list prices that solidifies the U.S. manufacturer’s influence in one of the world’s fastest-growing aviation markets.
Boeing (NYSE:BA) secured a historic foothold in Southeast Asia’s rapidly expanding aviation market as Vietnamese startup Sun PhuQuoc Airways placed an order for 40 787-9 Dreamliner jets.
Fortuna Mining (NYSE:FSM) capped a transformative fiscal year with record-breaking cash flow, signaling a successful pivot toward its high-margin West African gold assets even as it wrestled with operational hurdles in Latin America.
Materialise (NASDAQ:MTLS) reported fourth-quarter financial results that showcased the growing dominance of its healthcare division, helping the company achieve a significant jump in profitability despite a mixed macroeconomic backdrop.
Walldorf-based SAP (NYSE:SAP) today proposed a 6.4 percent increase to its annual dividend, signaling management’s confidence in the company’s pivot to the cloud after a fiscal year defined by record backlogs and a massive bet on generative AI.
AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo moved a step closer to expanding the use of their blockbuster cancer therapy, Enhertu, into the curative-intent setting for early-stage breast cancer.
Mark Zuckerberg testified that it's "very difficult" to enforce Instagram's age limits as he sought to defend the platform during a landmark trial over social media addiction. The chief executive officer of Meta Platforms was sharply questioned on the witness stand Wednesday about the company's efforts to attract and engage teenage users, and whether it adequately policed accounts belonging to children under 13, despite rules barring them from using the app. Zuckerberg said Meta has introduced some "proactive tools" to try to identify and remove accounts used by children under 13, but called it a "challenging" problem. Bloomberg News Senior Technology Reporter Kurt Wagner joins Bloomberg Businessweek Daily to discuss. He speaks with Carol Massar and Tim Stenovec.
Federal Communications Commission Chairman Brendan Carr defended the agency's rules regarding equal air time for political candidates and said the controversy over an interview between CBS late-night host Stephen Colbert and Texas state Representative James Talarico that never aired on the network wasn't the result of government censorship. Talarico, who is seeking a US Senate seat, used the incident to grab attention and campaign donations as he faces off against Congresswoman Jasmine Crockett in a closely watched primary race, according to Carr. Talarico's interview with Colbert was ultimately posted to the show's YouTube channel as an "online exclusive." Matthew Schettenhelm, Bloomberg Intelligence Media Litigation Analyst, and Bloomberg News Media Reporter Hannah Miller join Bloomberg Businessweek Daily to discuss. They speak with Carol Massar and Tim Stenovec.
